Polygenic Risk Score (PRS)
Estimate inherited risk for complex diseases (heart, breast & prostate) with Allelica-backed PRS—clear insights from your DNA.
Research & Development focus areas driving Novo Genomics innovation
Estimate inherited risk for complex diseases (heart, breast & prostate) with Allelica-backed PRS—clear insights from your DNA.
Genetic sex identification in <24 hours from minimal samples—built for urgent clinical decisions.
Map & analyze the gut microbiome to guide nutrition, immunity, metabolism—and long-term wellness.
Right drug, right dose: DNA-guided medication choices to improve effectiveness and reduce side effects.
Sequence the coding genome to uncover causes of rare and undiagnosed conditions for faster, clearer diagnoses.
AI model to predict response to FOLFOX in advanced colorectal cancer—supporting more precise, gentler care.
Your wellness blueprint: 100+ insights across health, nutrition, fitness, skin, sleep & medication response.
"When Sensitivity Matters." — Reverse-transcription PCR for pathogen detection and quantitative gene expression.
Earlier answers. Better outcomes — SMA screening: SMN1 exon 7 deletion and SMN2 copy-number analysis.
We use advanced genomic analysis to estimate an individual’s inherited risk for complex diseases such as heart disease, breast cancer, and prostate cancer. In partnership with Allelica, a global leader in polygenic risk scoring, we transform your DNA data into clear, personalized health insights.
From sample collection to sequencing and risk analysis, our process delivers results you can trust — without unnecessary complexity.
Knowing your genetic risk empowers you to take preventive action and make informed health decisions earlier in life.
Download BrochurePRS results are for informational and preventive purposes only and should not replace professional medical advice, diagnosis, or treatment. Consult a qualified healthcare provider for clinical decisions.
When every hour counts, our ultra-fast genetic testing pipeline can identify genetic sex in less than a day from a minimal sample such as a dried blood spot.
Rapid, accurate results mean faster treatment decisions in critical healthcare situations.
Download BrochureThis service is intended for clinical support in urgent care settings and is not available for non-medical or personal use. All results should be interpreted by qualified medical professionals.
The gut microbiome influences digestion, immunity, metabolism, and even mood. Our NovoBiome project maps and analyzes gut bacteria to help create personalized dietary and wellness strategies.
Understanding your “second genome” can lead to better long-term health and disease prevention.
Download BrochureMicrobiome analysis is for wellness and research purposes only and is not intended to diagnose, treat, or cure any medical condition. Lifestyle recommendations should be discussed with a healthcare professional.
Everyone’s genetic makeup affects how they respond to medication. Our PGx research identifies genetic markers that predict drug effectiveness and side effects.
Supporting clinicians in selecting and dosing medications based on a patient’s unique genetic profile.
This approach helps doctors choose the right medication at the right dose — the first time.
Download BrochurePGx testing is an aid to clinical decision-making and should not be the sole basis for prescribing or discontinuing any medication. All medication changes should be supervised by a licensed healthcare provider.
By sequencing the protein-coding regions of your genome, WES helps uncover the genetic causes of rare and undiagnosed medical conditions.
A faster, more accurate diagnosis means earlier treatment and better outcomes.
Download BrochureWES findings may include variants of uncertain significance. All genetic results should be confirmed and interpreted in a clinical context by a qualified medical geneticist.
OncoMaster AI is our predictive model that helps oncologists estimate how patients with advanced colorectal cancer may respond to FOLFOX chemotherapy.
AI-powered insights can improve treatment planning, reduce unnecessary side effects, and give patients more personalized care options.
Download BrochureOncoMaster AI is a decision-support tool for trained oncologists. It does not replace medical judgment and should be used in conjunction with standard diagnostic and treatment protocols.
WellDNA is a comprehensive genetic test that analyzes your predispositions in key areas — health, nutrition, fitness, skin, medication response, and sleep.
Insights into 33+ health conditions, 31+ nutrition parameters, 13 fitness traits, 29 skin parameters, 9 sleep factors, and response to 116+ medications. Includes genetic counseling, app-based access to reports, and personalized recommendations.
WellDNA helps you understand your unique genetic profile so you can make informed lifestyle, nutrition, and healthcare choices for long-term wellness.
Download BrochureWellDNA is intended for wellness, preventive health awareness, and educational purposes only. It is not a diagnostic tool and should not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making changes to your health regimen.
Clinical-grade RT-PCR pipeline for rapid, sensitive detection and quantification. Supports pathogen panels and targeted gene-expression assays with internal controls and robust LoD validation.
Accurate detection of SMN1 exon 7 deletion and SMN2 copy-number to assess SMA risk and guide management. Methods compatible with qPCR/MLPA/NGS depending on clinical context.